Oxybutynin Chloride, Extended-Release Tablets USP, 10 mg, 100 Tablet, Rx Only, Distributed by: La...
FDA Recall #D-0996-2019 — Class III — February 21, 2019
Product Description
Oxybutynin Chloride, Extended-Release Tablets USP, 10 mg, 100 Tablet, Rx Only, Distributed by: Lannett Company, Inc, Philadelphia, PA 19154 NDC: 62175-271-37
Reason for Recall
Failed Dissolution Specifications
Recalling Firm
Lannett Company Inc. — Seymour, IN
Classification
Class III — Not likely to cause adverse health consequences.
Product Type
Drugs
Product Quantity
14,448 bottles
Distribution
Nationwide, including Puerto Rico.
Code Information
Lots: 18226783A, exp 07/2021 and 18232540A, exp 08/2021
Status
Terminated
Voluntary / Mandated
N/A